Wize Pharma

Wize Pharma Net Debt

Delisted·Jan 10, 2019

The Net Debt of Wize Pharma (WIZP) as of Oct 11, 2026 is 265,000.00 USD.

Net Debt

265,000.00USD

Last updated:

Net Debt of Wize Pharma is 2020 265,000.00 USD. Net Debt of Wize Pharma was 2019 0.00 USD. It decreases by % higher compared to the previous year.

The Wize Pharma Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2014
2.46 M USD
Jan 1, 2015
3.69 M USD
Jan 1, 2016
4.46 M USD
Jan 1, 2017
3.20 M USD
Jan 1, 2018
2.64 M USD
Jan 1, 2019
0.00 USD
Jan 1, 2020
265,000.00 USD
The Wize Pharma Net Debt history
YEARNet DebtYoY
265,000.00USD—
0.00USD-100.00%
2.64 MUSD-17.76%
3.20 MUSD-28.15%
4.46 MUSD+20.84%
3.69 MUSD+50.18%
2.46 MUSD—
Access this data via the Eulerpool API
Get Free API Key

Wize Pharma Stock analysis

What does Wize Pharma do? Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wize Pharma stock

Net Debt of Wize Pharma is 265,000.00 USD in 2020.

On Eulerpool you can find the complete historical development of Net Debt Wize Pharma since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's Wize Pharma historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Wize Pharma

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Wize Pharma